The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence is taking over drug development,” claim some companies and researchers. Over the past few years, interest in using AI to design drugs and optimize clinical trials has driven a surge in research and investment. AI-driven platforms like AlphaFold, which won the 2024 Nobel Prize for its ability to predict the structure of proteins and design new ones, showcase AI’s potential to accelerate drug development. AI in drug discovery is “nonsense,” warn some industry veterans.…
Latest Post
Commission consults on EU securitisation rules
2025 will see huge advances in quantum computing. So what is a quantum chip and how does it work?
Government crackdown on explicit deepfakes
Loneliness and social isolation are linked to specific proteins – new research
What fan culture and mourning can teach us about grief
Microbes can colonize space, produce drugs and create energy − researchers are simulating their inner workings to harness how